The medical community is demonstrating considerable attention in Asenlix, a relatively developed therapy designed to treat the impact of mood disorders. Unlike established antidepressants that primarily target on serotonin, Asenlix offers a novel mechanism of function, possibly impacting multiple neurotransmitter pathways involved in psychological